Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Arendrup

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 1, 2011
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteriaM A Pfaller, D J Diekema, D Andes, et al.
Scandinavian Journal of Infectious Diseases|November 22, 2008
A nosocomial outbreak of Candida parapsilosis in southern Sweden verified by genotypingAnna Brillowska-Dabrowska, T Schön, S Pannanusorn, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 5, 2011
A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibilityK L Mortensen, H K Johansen, K Fuursted, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 6, 2018
Multicentre determination of rezafungin (CD101) susceptibility of Candida species by the EUCAST methodM C Arendrup, J Meletiadis, O Zaragoza, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 26, 2008
Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibilityM C Arendrup, K Fuursted, B Gahrn-Hansen, et al.
Medical Mycology|April 17, 2008
Experimental guinea pig model of dermatophytosis: a simple and useful tool for the evaluation of new diagnostics and antifungalsD M Saunte, J P Hasselby, A Brillowska-Dabrowska, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 25, 2011
Differentiation of Candida glabrata, C. nivariensis and C. bracarensis based on fragment length polymorphism of ITS1 and ITS2 and restriction fragment length polymorphism of ITS and D1/D2 regions in rDNAH Mirhendi, B Bruun, H C Schønheyder, et al.
Antimicrobial Agents and Chemotherapy|June 18, 2014
First detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environmentK M T Astvad, R H Jensen, T M Hassan, et al.
Epidemiology and Infection|April 28, 2009
Blastocystis: unravelling potential risk factors and clinical significance of a common but neglected parasiteC R Stensvold, H C Lewis, A M Hammerum, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2011
Disseminated Candidiasis caused by Candida albicans with amino acid substitutions in Fks1 at position Ser645 cannot be successfully treated with micafunginJ L Slater, S J Howard, A Sharp, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 1, 2011
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteriaM A Pfaller, D J Diekema, D Andes, et al.
Scandinavian Journal of Infectious Diseases|November 22, 2008
A nosocomial outbreak of Candida parapsilosis in southern Sweden verified by genotypingAnna Brillowska-Dabrowska, T Schön, S Pannanusorn, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 5, 2011
A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibilityK L Mortensen, H K Johansen, K Fuursted, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 6, 2018
Multicentre determination of rezafungin (CD101) susceptibility of Candida species by the EUCAST methodM C Arendrup, J Meletiadis, O Zaragoza, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 26, 2008
Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibilityM C Arendrup, K Fuursted, B Gahrn-Hansen, et al.
Medical Mycology|April 17, 2008
Experimental guinea pig model of dermatophytosis: a simple and useful tool for the evaluation of new diagnostics and antifungalsD M Saunte, J P Hasselby, A Brillowska-Dabrowska, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 25, 2011
Differentiation of Candida glabrata, C. nivariensis and C. bracarensis based on fragment length polymorphism of ITS1 and ITS2 and restriction fragment length polymorphism of ITS and D1/D2 regions in rDNAH Mirhendi, B Bruun, H C Schønheyder, et al.
Antimicrobial Agents and Chemotherapy|June 18, 2014
First detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environmentK M T Astvad, R H Jensen, T M Hassan, et al.
Epidemiology and Infection|April 28, 2009
Blastocystis: unravelling potential risk factors and clinical significance of a common but neglected parasiteC R Stensvold, H C Lewis, A M Hammerum, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2011
Disseminated Candidiasis caused by Candida albicans with amino acid substitutions in Fks1 at position Ser645 cannot be successfully treated with micafunginJ L Slater, S J Howard, A Sharp, et al.
Pageof 7